What Does Pear Therapeutics Do?

Total employees0
HeadquartersBoston
Founded2013

Pear Therapeutics was a biotechnology company that pioneered the development and commercialization of Prescription Digital Therapeutics (PDTs). These are software-based treatments designed to address a range of serious diseases, including substance use disorder, opioid use disorder, and chronic insomnia. The company achieved FDA authorization for several of its products, such as reSET®, reSET-O®, and Somryst®. Despite its innovations and early successes, Pear Therapeutics faced commercialization challenges and filed for Chapter 11 bankruptcy in April 2023. Its assets were subsequently sold, marking the end of its operations as an independent entity. The company's work laid significant groundwork for the broader field of digital therapeutics.

Where Is Pear Therapeutics's Headquarters?

HQ Function

The Boston headquarters served as the central hub for Pear Therapeutics' research and development, clinical operations, commercial strategy, and corporate administration.

Notable Features:

Located in a prominent commercial district, the headquarters likely featured modern office facilities designed to support a collaborative and innovative work environment for its diverse teams.

Work Culture:

The work culture at Pear Therapeutics was reportedly dynamic and mission-driven, focused on pioneering a new class of therapeutics. Employees were often passionate about the potential of PDTs to improve patient lives, though the startup environment also came with high-pressure demands.

HQ Significance:

The Boston location was significant due to its proximity to leading academic institutions, hospitals, and a rich ecosystem of talent in the life sciences and technology sectors, which was crucial for Pear's R&D and talent acquisition.

Values Reflected in HQ: The choice of a major innovation hub like Boston likely reflected Pear's values of scientific rigor, cutting-edge development, and ambition to transform healthcare.

Location:

While primarily focused on the U.S. market where its initial products received FDA authorization, Pear Therapeutics had aspirations for global expansion. They engaged in early-stage discussions and partnerships to explore market access in regions like Europe and Asia. However, these efforts did not reach full commercialization globally before the company's bankruptcy. Functions supported globally were mainly related to regulatory strategy, partnership development, and initial market assessment.

Street Address:

3 Post Office Square, 3rd Floor

City:

Boston

State/Province:

MA

Country:

USA

Where Else Does Pear Therapeutics Operate Around the World?

San Francisco, CA, USA

Address: Specific street address not publicly available post-bankruptcy. Formerly located in the SOMA or Financial District area.

To tap into the rich technology and digital health ecosystem of the San Francisco Bay Area, fostering innovation in their software-based therapeutics.

Raleigh, NC, USA

Address: Specific street address not publicly available post-bankruptcy. Formerly located in the Research Triangle Park vicinity.

To leverage the clinical research infrastructure and talent pool in the Research Triangle Park area, supporting the development and validation of their PDTs.

Buying Intent Signals for Pear Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Pear Therapeutics? Meet the Executive Team

As of April 2025, Pear Therapeutics' leadership includes:

Corey McCann, M.D., Ph.D. - Former President and Chief Executive Officer
Chris Guiffre - Former Chief Financial Officer and Chief Operating Officer
Yuri Maricich, M.D. - Former Chief Medical Officer
Julia Strandberg - Former Chief Commercial Officer
McKinley Plowman - Former Chief People Officer

Who's Investing in Pear Therapeutics?

Pear Therapeutics has been backed by several prominent investors over the years, including:

Temasek
SoftBank Vision Fund 2
Novartis
Khosla Ventures
5AM Ventures
Jazz Venture Partners
Trustbridge Partners
The Bridge Builders Collaborative
ETRरिया (Error corrected to: EDBI - Singapore)

What Leadership Changes Has Pear Therapeutics Seen Recently?

Hire0
Exits0

In the 12 months prior to its bankruptcy filing in April 2023, Pear Therapeutics saw some executive changes typical of a company navigating challenging market conditions. The most significant event was the departure of the entire executive team following the bankruptcy and asset sale. As the company ceased operations in April 2023, there have been no new hires or exits from Pear Therapeutics itself in the past 12 months from the current date (May 2024).

Departures

Entire Executive Team, The entire executive team, including CEO Corey McCann, departed following Pear Therapeutics' Chapter 11 bankruptcy filing and subsequent asset sale. (Note: This event is slightly outside the 'last 12 months' from May 2024, but is the most relevant final executive event).

What Technology (Tech Stack) Is Used byPear Therapeutics?

Discover the tools Pear Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Pear Therapeutics Email Formats and Examples

Pear Therapeutics likely utilized common corporate email formats. As the company is no longer operational, these email addresses are inactive.

[first_initial][last]@peartherapeutics.com

Format

jdoe@peartherapeutics.com

Example

0%

Success rate

What's the Latest News About Pear Therapeutics?

Fierce BiotechMay 26, 2023

Pear Therapeutics' assets sold to 4 buyers for $6.05M after bankruptcy

Four companies, including Click Therapeutics, acquired the assets of bankrupt Pear Therapeutics for a total of $6.05 million. Click obtained Pear's schizophrenia and depression assets, along with its PDT discovery platform....more

Endpoints NewsApril 7, 2023

Pear Therapeutics files for Chapter 11 bankruptcy, plans to sell assets

Pear Therapeutics filed for Chapter 11 bankruptcy protection and announced plans to sell its business or assets. The company cited challenges in securing reimbursement and market adoption for its prescription digital therapeutics....more

Fierce BiotechJanuary 5, 2023

Pear Therapeutics lays off 22% of staff, warns more cuts could come without new financing or M&A deal

Pear Therapeutics laid off 59 employees, or 22% of its workforce, as part of a restructuring plan to reduce operating expenses amid financial difficulties and challenges in the digital therapeutics market....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Pear Therapeutics, are just a search away.